Omnicell, Inc. (OMCL)
USD 31.35
(-4.1%)
USD 31.35
(-4.1%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.37 Million USD | -460.68% |
| 2022 | 5.64 Million USD | -92.74% |
| 2021 | 77.84 Million USD | 141.81% |
| 2020 | 32.19 Million USD | -47.51% |
| 2019 | 61.33 Million USD | 62.58% |
| 2018 | 37.72 Million USD | 83.11% |
| 2017 | 20.6 Million USD | 3317.08% |
| 2016 | 603 Thousand USD | -98.04% |
| 2015 | 30.76 Million USD | 0.79% |
| 2014 | 30.51 Million USD | 27.27% |
| 2013 | 23.97 Million USD | 48.38% |
| 2012 | 16.16 Million USD | 55.56% |
| 2011 | 10.38 Million USD | 112.37% |
| 2010 | 4.89 Million USD | 1001.8% |
| 2009 | 444 Thousand USD | -96.51% |
| 2008 | 12.72 Million USD | -70.61% |
| 2007 | 43.29 Million USD | 317.7% |
| 2006 | 10.36 Million USD | 599.76% |
| 2005 | -2.07 Million USD | -119.56% |
| 2004 | 10.6 Million USD | 45.09% |
| 2003 | 7.3 Million USD | 245.04% |
| 2002 | -5.03 Million USD | -331.71% |
| 2001 | -1.16 Million USD | 94.39% |
| 2000 | -20.78 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 8.63 Million USD | 131.06% |
| 2024 Q1 | -15.67 Million USD | -9.05% |
| 2024 Q2 | 3.73 Million USD | 123.83% |
| 2023 Q1 | -15 Million USD | 47.2% |
| 2023 Q3 | 5.55 Million USD | 60.91% |
| 2023 Q4 | -14.37 Million USD | -358.87% |
| 2023 Q2 | 3.45 Million USD | 123.01% |
| 2023 FY | -20.37 Million USD | -460.68% |
| 2022 Q1 | 8.21 Million USD | -41.26% |
| 2022 Q3 | 16.77 Million USD | 84.96% |
| 2022 Q2 | 9.06 Million USD | 10.42% |
| 2022 Q4 | -28.4 Million USD | -269.36% |
| 2022 FY | 5.64 Million USD | -92.74% |
| 2021 Q4 | 13.98 Million USD | -52.31% |
| 2021 Q3 | 29.31 Million USD | 43.54% |
| 2021 Q2 | 20.42 Million USD | 44.57% |
| 2021 FY | 77.84 Million USD | 141.81% |
| 2021 Q1 | 14.12 Million USD | -13.74% |
| 2020 Q3 | 8.8 Million USD | 304.82% |
| 2020 Q2 | -4.29 Million USD | -138.01% |
| 2020 Q1 | 11.31 Million USD | -48.81% |
| 2020 FY | 32.19 Million USD | -47.51% |
| 2020 Q4 | 16.37 Million USD | 86.0% |
| 2019 Q2 | 15.97 Million USD | 386.48% |
| 2019 FY | 61.33 Million USD | 62.58% |
| 2019 Q4 | 22.09 Million USD | 10.57% |
| 2019 Q1 | 3.28 Million USD | -77.8% |
| 2019 Q3 | 19.98 Million USD | 25.08% |
| 2018 Q1 | 2.72 Million USD | -88.8% |
| 2018 Q3 | 13.62 Million USD | 106.86% |
| 2018 Q4 | 14.79 Million USD | 8.55% |
| 2018 FY | 37.72 Million USD | 83.11% |
| 2018 Q2 | 6.58 Million USD | 142.21% |
| 2017 Q3 | 7.74 Million USD | 825.69% |
| 2017 Q1 | -10.75 Million USD | -6949.68% |
| 2017 FY | 20.6 Million USD | 3317.08% |
| 2017 Q4 | 24.29 Million USD | 213.51% |
| 2017 Q2 | 837 Thousand USD | 107.78% |
| 2016 Q4 | 157 Thousand USD | -92.08% |
| 2016 FY | 603 Thousand USD | -98.04% |
| 2016 Q3 | 1.98 Million USD | 271.1% |
| 2016 Q2 | -1.15 Million USD | -206.61% |
| 2016 Q1 | -378 Thousand USD | -104.94% |
| 2015 FY | 30.76 Million USD | 0.79% |
| 2015 Q4 | 7.65 Million USD | -4.74% |
| 2015 Q3 | 8.03 Million USD | -8.17% |
| 2015 Q2 | 8.75 Million USD | 38.51% |
| 2015 Q1 | 6.31 Million USD | -31.59% |
| 2014 Q4 | 9.23 Million USD | 26.52% |
| 2014 FY | 30.51 Million USD | 27.27% |
| 2014 Q1 | 6.19 Million USD | -9.22% |
| 2014 Q2 | 7.78 Million USD | 25.75% |
| 2014 Q3 | 7.3 Million USD | -6.28% |
| 2013 Q4 | 6.82 Million USD | -12.02% |
| 2013 Q2 | 6.01 Million USD | 77.73% |
| 2013 Q3 | 7.75 Million USD | 28.91% |
| 2013 Q1 | 3.38 Million USD | -38.81% |
| 2013 FY | 23.97 Million USD | 48.38% |
| 2012 Q1 | 2.35 Million USD | -43.19% |
| 2012 Q2 | 1.37 Million USD | -41.51% |
| 2012 Q3 | 6.92 Million USD | 403.27% |
| 2012 Q4 | 5.53 Million USD | -20.06% |
| 2012 FY | 16.16 Million USD | 55.56% |
| 2011 Q2 | 2.58 Million USD | 286.12% |
| 2011 Q4 | 4.13 Million USD | 38.21% |
| 2011 FY | 10.38 Million USD | 112.37% |
| 2011 Q1 | 670 Thousand USD | -0.3% |
| 2011 Q3 | 2.99 Million USD | 15.73% |
| 2010 Q3 | 1.27 Million USD | -35.06% |
| 2010 Q2 | 1.96 Million USD | 100.72% |
| 2010 Q1 | 979 Thousand USD | 76.08% |
| 2010 FY | 4.89 Million USD | 1001.8% |
| 2010 Q4 | 672 Thousand USD | -47.34% |
| 2009 Q2 | 904 Thousand USD | 148.32% |
| 2009 FY | 444 Thousand USD | -96.51% |
| 2009 Q3 | 854 Thousand USD | -5.53% |
| 2009 Q1 | -1.87 Million USD | -156.3% |
| 2009 Q4 | 556 Thousand USD | -34.89% |
| 2008 Q3 | 2.91 Million USD | 5.85% |
| 2008 Q2 | 2.75 Million USD | -26.25% |
| 2008 Q1 | 3.73 Million USD | -73.89% |
| 2008 Q4 | 3.32 Million USD | 14.04% |
| 2008 FY | 12.72 Million USD | -70.61% |
| 2007 Q3 | 6.94 Million USD | -61.64% |
| 2007 Q2 | 18.09 Million USD | 356.32% |
| 2007 Q1 | 3.96 Million USD | -19.23% |
| 2007 Q4 | 14.29 Million USD | 106.01% |
| 2007 FY | 43.29 Million USD | 317.7% |
| 2006 FY | 10.36 Million USD | 599.76% |
| 2006 Q1 | 1.01 Million USD | -54.58% |
| 2006 Q2 | 2.13 Million USD | 109.94% |
| 2006 Q3 | 3.11 Million USD | 46.09% |
| 2006 Q4 | 4.9 Million USD | 57.54% |
| 2005 Q4 | 2.23 Million USD | 58.09% |
| 2005 FY | -2.07 Million USD | -119.56% |
| 2005 Q3 | 1.41 Million USD | 2043.94% |
| 2005 Q1 | -5.79 Million USD | -321.15% |
| 2005 Q2 | 66 Thousand USD | 101.14% |
| 2004 Q2 | 2.37 Million USD | 0.81% |
| 2004 Q1 | 2.35 Million USD | -27.41% |
| 2004 FY | 10.6 Million USD | 45.09% |
| 2004 Q4 | 2.61 Million USD | -19.56% |
| 2004 Q3 | 3.25 Million USD | 37.21% |
| 2003 Q4 | 3.24 Million USD | 39.36% |
| 2003 Q3 | 2.32 Million USD | 80.25% |
| 2003 Q2 | 1.29 Million USD | 190.77% |
| 2003 Q1 | 444 Thousand USD | 107.55% |
| 2003 FY | 7.3 Million USD | 245.04% |
| 2002 Q3 | -2.58 Million USD | -245.33% |
| 2002 Q4 | -5.88 Million USD | -127.63% |
| 2002 Q1 | 1.65 Million USD | 18.03% |
| 2002 Q2 | 1.77 Million USD | 7.76% |
| 2002 FY | -5.03 Million USD | -331.71% |
| 2001 FY | -1.16 Million USD | 94.39% |
| 2001 Q1 | -1.84 Million USD | 0.0% |
| 2001 Q3 | 491 Thousand USD | 140.55% |
| 2001 Q4 | 1.39 Million USD | 184.73% |
| 2001 Q2 | -1.21 Million USD | 34.36% |
| 2000 FY | -20.78 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CareCloud, Inc. | -48.67 Million USD | 58.148% |
| Augmedix, Inc. | -19.17 Million USD | -6.259% |
| BrightSpring Health Services, Inc. Common Stock | -154.6 Million USD | 86.824% |
| CareCloud, Inc. | -48.67 Million USD | 58.148% |
| HealthEquity, Inc. | 55.71 Million USD | 136.565% |
| iCoreConnect Inc. | -15.55 Million USD | -30.989% |
| Inovalon Holdings, Inc. | 22.57 Million USD | 190.221% |
| Nutex Health, Inc. | -45.78 Million USD | 55.509% |
| OneMedNet Corporation | -23.2 Million USD | 12.215% |
| Progyny, Inc. | 62.03 Million USD | 132.837% |
| Renalytix Plc | -33.45 Million USD | 39.111% |
| Schrödinger, Inc. | 40.72 Million USD | 150.027% |
| Simulations Plus, Inc. | 9.95 Million USD | 304.651% |
| SOPHiA GENETICS SA | -78.98 Million USD | 74.208% |
| Streamline Health Solutions, Inc. | -18.69 Million USD | -8.953% |
| Ontrak, Inc. | -27.92 Million USD | 27.038% |
| GE HealthCare Technologies Inc. | 1.56 Billion USD | 101.299% |
| Sharecare, Inc. | -128.49 Million USD | 84.147% |
| Aclarion, Inc. | -4.91 Million USD | -314.772% |
| CareMax, Inc. | -683.34 Million USD | 97.019% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.35 Million USD | -280.349% |
| Forian Inc. | 11.1 Million USD | 283.412% |
| Bullfrog AI Holdings, Inc. Warrants | -5.35 Million USD | -280.349% |
| HeartBeam, Inc. | -14.63 Million USD | -39.156% |
| GeneDx Holdings Corp. | -175.76 Million USD | 88.41% |
| SCWorx Corp. | -3.98 Million USD | -411.687% |
| Minerva Surgical, Inc. | -34.11 Million USD | 40.282% |
| Definitive Healthcare Corp. | -202.38 Million USD | 89.935% |
| 10x Genomics, Inc. | -255.09 Million USD | 92.014% |
| Zhongchao Inc. | -11.33 Million USD | -79.703% |
| Accolade, Inc. | -99.8 Million USD | 79.589% |
| MSP Recovery, Inc. | -56.34 Million USD | 63.848% |
| R1 RCM Inc. | 3.3 Million USD | 717.303% |
| Spok Holdings, Inc. | 15.66 Million USD | 230.033% |
| Privia Health Group, Inc. | 23.07 Million USD | 188.266% |
| EUDA Health Holdings Limited | -10.03 Million USD | -102.909% |
| TruBridge, Inc. | -45.78 Million USD | 55.511% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | -154.6 Million USD | 86.824% |
| Sharecare, Inc. | -128.49 Million USD | 84.147% |
| Health Catalyst, Inc. | -118.14 Million USD | 82.758% |
| GoodRx Holdings, Inc. | -8.86 Million USD | -129.714% |
| Premier, Inc. | 119.54 Million USD | 117.041% |
| HealthStream, Inc. | 15.21 Million USD | 233.905% |
| Certara, Inc. | -55.35 Million USD | 63.201% |
| GeneDx Holdings Corp. | -175.76 Million USD | 88.41% |
| Ontrak, Inc. | -27.92 Million USD | 27.038% |
| SHL Telemedicine Ltd. | -7.05 Million USD | -188.705% |
| CareCloud, Inc. | -48.67 Million USD | 58.148% |
| EUDA Health Holdings Limited | -10.03 Million USD | -102.909% |
| HeartBeam, Inc. | -14.63 Million USD | -39.156% |
| Mangoceuticals, Inc. | -9.21 Million USD | -121.125% |
| CareMax, Inc. | -683.34 Million USD | 97.019% |
| Healthcare Triangle, Inc. | -12.33 Million USD | -65.094% |
| National Research Corporation | 30.97 Million USD | 165.774% |
| Aclarion, Inc. | -4.91 Million USD | -314.772% |
| OptimizeRx Corporation | -17.56 Million USD | -15.969% |